Recombinant Thrombopoietin Effectively Shortens the Time to Response and Increases Platelet Counts in Elderly Patients with Severe Immune Thrombocytopenia

Background: This study was conducted to investigate the short-term efficacy and safety of rhTPO for the management of severe ITP in the elderly as first-line treatment. Methods: A total of 54 elderly patients with severe ITP were studied, including 39 patients treated with a combination regimen of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Sun, Lihua, Li, Feng, Li, Ying, Hou, Yunhua, Meng, Yahong, Fan, Xiaohong, Cheng, Yunfeng, Hua, Fanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573713/
https://www.ncbi.nlm.nih.gov/pubmed/36233631
http://dx.doi.org/10.3390/jcm11195763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573713/
https://www.ncbi.nlm.nih.gov/pubmed/36233631
http://dx.doi.org/10.3390/jcm11195763

Ejemplares similares